149 related articles for article (PubMed ID: 20041321)
1. Ivermectin is a nonselective inhibitor of mammalian P-type ATPases.
Pimenta PH; Silva CL; Noël F
Naunyn Schmiedebergs Arch Pharmacol; 2010 Feb; 381(2):147-52. PubMed ID: 20041321
[TBL] [Abstract][Full Text] [Related]
2. Δ²,³-ivermectin ethyl secoester, a conjugated ivermectin derivative with leishmanicidal activity but without inhibitory effect on mammalian P-type ATPases.
Noël F; Pimenta PH; Dos Santos AR; Tomaz EC; Quintas LE; Kaiser CR; Silva CL; Férézou JP
Naunyn Schmiedebergs Arch Pharmacol; 2011 Jan; 383(1):101-7. PubMed ID: 21088826
[TBL] [Abstract][Full Text] [Related]
3. 2-Methoxy-3,8,9-trihydroxy coumestan: a new synthetic inhibitor of Na+,K+-ATPase with an original mechanism of action.
Pôças ES; Costa PR; da Silva AJ; Noël F
Biochem Pharmacol; 2003 Dec; 66(11):2169-76. PubMed ID: 14609741
[TBL] [Abstract][Full Text] [Related]
4. In vitro effect of valepotriates isolated from Valeriana glechomifolia on rat P-type ATPases.
Bettero GM; Salles L; Rosário Figueira RM; Poser Gv; Rates SM; Noël F; Quintas LE
Planta Med; 2011 Oct; 77(15):1702-6. PubMed ID: 21567360
[TBL] [Abstract][Full Text] [Related]
5. Insights into the mechanism of Na+,K+-ATPase inhibition by 2-methoxy-3,8,9-trihydroxy coumestan.
Pôças ES; Touza NA; Pimenta PH; Leitão FB; Neto CD; da Silva AJ; Costa PR; Noël F
Bioorg Med Chem; 2008 Oct; 16(19):8801-5. PubMed ID: 18805699
[TBL] [Abstract][Full Text] [Related]
6. Cardiac Na+,K+-ATPase isoenzymes: sensitivity to prednisolone bisguanylhydrazone.
Ng YC; Leung WY; Akera T
Eur J Pharmacol; 1988 Oct; 155(1-2):93-9. PubMed ID: 2854075
[TBL] [Abstract][Full Text] [Related]
7. An Na+/K(+)-ATPase inhibitor protein from rat brain cytosol.
Chandra S; Adhikary G; Sikdar R; Sen PC
Biochim Biophys Acta; 1993 Aug; 1144(1):33-8. PubMed ID: 8394134
[TBL] [Abstract][Full Text] [Related]
8. [Molecular and functional diversity of NA,K-ATPase and renal H,K-ATPases].
Jaisser F
Nephrologie; 1996; 17(7):401-8. PubMed ID: 9019667
[TBL] [Abstract][Full Text] [Related]
9. Na+,K(+)-ATPase inhibition by an endogenous peptide, SPAI-1, isolated from porcine duodenum.
Ishizuka N; Fukushima Y; Urayama O; Akera T
Biochim Biophys Acta; 1991 Nov; 1069(2):259-66. PubMed ID: 1657169
[TBL] [Abstract][Full Text] [Related]
10. Role of homologous ASP334 and GLU319 in human non-gastric H,K- and Na,K-ATPases in cardiac glycoside binding.
Radkov R; Kharoubi-Hess S; Schaer D; Modyanov NN; Geering K; Horisberger JD
Biochem Biophys Res Commun; 2007 Apr; 356(1):142-6. PubMed ID: 17349614
[TBL] [Abstract][Full Text] [Related]
11. The inhibition of the sarcoplasmic/endoplasmic reticulum Ca2+-ATPase by macrocyclic lactones and cyclosporin A.
Bilmen JG; Wootton LL; Michelangeli F
Biochem J; 2002 Aug; 366(Pt 1):255-63. PubMed ID: 12022919
[TBL] [Abstract][Full Text] [Related]
12. Isoform-specific stimulation of cardiac Na/K pumps by nanomolar concentrations of glycosides.
Gao J; Wymore RS; Wang Y; Gaudette GR; Krukenkamp IB; Cohen IS; Mathias RT
J Gen Physiol; 2002 Apr; 119(4):297-312. PubMed ID: 11929882
[TBL] [Abstract][Full Text] [Related]
13. Inhibition of P-type ATPases by [(dihydroindenyl)oxy]acetic acid (DIOA), a K+ -Cl- cotransporter inhibitor.
Fujii T; Ohira Y; Itomi Y; Takahashi Y; Asano S; Morii M; Takeguchi N; Sakai H
Eur J Pharmacol; 2007 Apr; 560(2-3):123-6. PubMed ID: 17303113
[TBL] [Abstract][Full Text] [Related]
14. AlF4- reversibly inhibits 'P'-type cation-transport ATPases, possibly by interacting with the phosphate-binding site of the ATPase.
Missiaen L; Wuytack F; De Smedt H; Vrolix M; Casteels R
Biochem J; 1988 Aug; 253(3):827-33. PubMed ID: 2845938
[TBL] [Abstract][Full Text] [Related]
15. In vivo and in vitro effects of aldrin on rat brain synaptosomal Mg2+ and Na+,K(+)-adenosine triphosphatase.
Chandra M; Poddar MK
Biochem Pharmacol; 1990 Oct; 40(7):1449-56. PubMed ID: 2171528
[TBL] [Abstract][Full Text] [Related]
16. Isoform specificity of cardiac glycosides binding to human Na+,K+-ATPase alpha1beta1, alpha2beta1 and alpha3beta1.
Hauck C; Potter T; Bartz M; Wittwer T; Wahlers T; Mehlhorn U; Scheiner-Bobis G; McDonough AA; Bloch W; Schwinger RH; Müller-Ehmsen J
Eur J Pharmacol; 2009 Nov; 622(1-3):7-14. PubMed ID: 19751721
[TBL] [Abstract][Full Text] [Related]
17. Effects of two putative endogenous digitalis-like factors, marinobufagenin and ouabain, on the Na+, K+-pump in human mesenteric arteries.
Bagrov AY; Fedorova OV
J Hypertens; 1998 Dec; 16(12 Pt 2):1953-8. PubMed ID: 9886882
[TBL] [Abstract][Full Text] [Related]
18. Effect of tissue specificity of brain soluble fractions on Na+, K(+)-ATPase activity.
Rodríguez de Lores Arnaiz G
Neurochem Res; 1990 Mar; 15(3):289-94. PubMed ID: 2164167
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Na+,K+-ATPase activity from rat hippocampus by proline.
Pontes ZL; Oliveira LS; Franzon R; Wajner M; Wannmacher CM; Wyse AT
Neurochem Res; 2001 Dec; 26(12):1321-6. PubMed ID: 11885784
[TBL] [Abstract][Full Text] [Related]
20. Reduced Na-K pump but increased Na-K-2Cl cotransporter in aorta of streptozotocin-induced diabetic rat.
Michea L; Irribarra V; Goecke IA; Marusic ET
Am J Physiol Heart Circ Physiol; 2001 Feb; 280(2):H851-8. PubMed ID: 11158986
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
